mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for ACADVL
Gene summary
Basic gene Info.Gene symbolACADVL
Gene nameacyl-CoA dehydrogenase, very long chain
SynonymsACAD6|LCACD|VLCAD
CytomapUCSC genome browser: 17p13.1
Type of geneprotein-coding
RefGenesNM_000018.3,
NM_001033859.2,NM_001270447.1,NM_001270448.1,
Descriptionacyl-Coenzyme A dehydrogenase, very long chainvery long-chain specific acyl-CoA dehydrogenase, mitochondrial
Modification date20141219
dbXrefs MIM : 609575
HGNC : HGNC
Ensembl : ENSG00000072778
HPRD : 01940
Vega : OTTHUMG00000102157
ProteinUniProt: P49748
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_ACADVL
BioGPS: 37
PathwayNCI Pathway Interaction Database: ACADVL
KEGG: ACADVL
REACTOME: ACADVL
Pathway Commons: ACADVL
ContextiHOP: ACADVL
ligand binding site mutation search in PubMed: ACADVL
UCL Cancer Institute: ACADVL
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for ACADVL

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
D466D466GCOAD2
I457R456CBRCA1
G222G222RCOAD1
F214A213TGBM1
D466D466NOV1
I457R456HUCEC1
I457R456CUCEC1
G175V174MUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for ACADVL
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
I457R456H-1.4475287
I457R456C-1.157958
F214A213T-1.0524902
G175V174M-0.69926689
D466D466N-0.44360705
D466D466G-0.42080846
G222G222R-0.16458305
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for ACADVL from PDB
PDB IDPDB titlePDB structure
2UXWCRYSTAL STRUCTURE OF HUMAN VERY LONG CHAIN ACYL-COA DEHYDROGENASE (ACADVL)

Top
Differential gene expression and gene-gene network for ACADVL
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of ACADVL and the right PPI network was created from samples without mutations in the LBS of ACADVL. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for ACADVL
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0342784VLCAD deficiency9Biomarker, GeneticVariation
umls:C0003130Anoxia1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs
98197V174MPathogenicGermlineGeneReviews:NBK6816
MedGen:C0342784
OMIM:201460
OMIM:201475
Orphanet:ORPHA26793
SNOMED CT:237996001
SNOMED CT:237997005
MedGen:CN221809
98200G222RLikely pathogenic;Uncertain significanceGermline;unknownGeneReviews:NBK6816
MedGen:C0342784
OMIM:201460
OMIM:201475
Orphanet:ORPHA26793
SNOMED CT:237996001
SNOMED CT:237997005
MedGen:CN221809
191478R456CUncertain significanceGermlineMedGen:CN221809
191479R456HUncertain significanceGermlineMedGen:CN221809
195844A213TPathogenicGermlineGeneReviews:NBK6816
MedGen:C0342784
OMIM:201460
OMIM:201475
Orphanet:ORPHA26793
SNOMED CT:237996001
SNOMED CT:237997005
MedGen:CN221809

Top
Pharmacological information for ACADVL
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of ACADVL go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
FADFAD2uxwAF214 G222 I457 D466
TH3TRANS DELTA2 PALMITENOYL-COENZYMEA2uxwAG175 F214 G222


Top
Conservation information for LBS of ACADVL
Multiple alignments for P49748 in multiple species
LBSAA sequence# speciesSpecies
D466FEGTNDILRLF3Homo sapiens, Rattus norvegicus, Bos taurus
D466FEGANDILRLF1Mus musculus
E462IFRIFEGTNDI3Homo sapiens, Rattus norvegicus, Bos taurus
E462IFRIFEGANDI1Mus musculus
F214QALAAFCLTEP2Mus musculus, Rattus norvegicus
F214ETVAAFCLTEP1Homo sapiens
F214ETIAAFCLTEP1Bos taurus
F461RIFRIFEGTND3Homo sapiens, Rattus norvegicus, Bos taurus
F461RIFRIFEGAND1Mus musculus
G175HDLGVSVTLGA2Mus musculus, Rattus norvegicus
G175HDLGVGITLGA1Homo sapiens
G175YDLGVGIVLGA1Bos taurus
G179VSVTLGAHQSI2Mus musculus, Rattus norvegicus
G179VGITLGAHQSI1Homo sapiens
G179VGIVLGAHQSI1Bos taurus
G222TEPSSGSDAAS2Homo sapiens, Bos taurus
G222TEPSSGSDVAS2Mus musculus, Rattus norvegicus
G463FRIFEGTNDIL3Homo sapiens, Rattus norvegicus, Bos taurus
G463FRIFEGANDIL1Mus musculus
I176DLGVSVTLGAH2Mus musculus, Rattus norvegicus
I176DLGVGITLGAH1Homo sapiens
I176DLGVGIVLGAH1Bos taurus
I184GAHQSIGFKGI4Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus
I250GSKIWISNGGL3Mus musculus, Rattus norvegicus, Bos taurus
I250GSKLWISNGGL1Homo sapiens
I457LRDLRIFRIFE2Homo sapiens, Bos taurus
I457LRDIRIFRIFE2Mus musculus, Rattus norvegicus
I467EGTNDILRLFV3Homo sapiens, Rattus norvegicus, Bos taurus
I467EGANDILRLFV1Mus musculus
K299GPPEKKMGIKA2Homo sapiens, Bos taurus
K299GLPEKKMGIKA2Mus musculus, Rattus norvegicus
L144LGAFGLQVPSE3Homo sapiens, Mus musculus, Rattus norvegicus
L144LGAFGLQVPNE1Bos taurus
L178GVSVTLGAHQS2Mus musculus, Rattus norvegicus
L178GVGITLGAHQS1Homo sapiens
L178GVGIVLGAHQS1Bos taurus
L216LAAFCLTEPSS2Mus musculus, Rattus norvegicus
L216VAAFCLTEPSS1Homo sapiens
L216IAAFCLTEPSS1Bos taurus
L337VAMHILNNGRF2Homo sapiens, Bos taurus
L337VAVNILNNGRF2Mus musculus, Rattus norvegicus
Q562GIVNEQFLLQR3Homo sapiens, Mus musculus, Rattus norvegicus
Q562DIINEQFLLQR1Bos taurus
S223EPSSGSDAASI2Homo sapiens, Bos taurus
S223EPSSGSDVASI2Mus musculus, Rattus norvegicus
S251SKIWISNGGLA3Mus musculus, Rattus norvegicus, Bos taurus
S251SKLWISNGGLA1Homo sapiens
T217AAFCLTEPSSG4Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus
T464RIFEGTNDILR3Homo sapiens, Rattus norvegicus, Bos taurus
T464RIFEGANDILR1Mus musculus
V164QYARLVEIVGM2Homo sapiens, Bos taurus
V164QYARLAEIVGM2Mus musculus, Rattus norvegicus
W249NGSKIWISNGG3Mus musculus, Rattus norvegicus, Bos taurus
W249NGSKLWISNGG1Homo sapiens
Y160LCNTQYARLVE2Homo sapiens, Bos taurus
Y160LSNTQYARLAE2Mus musculus, Rattus norvegicus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas